492 related articles for article (PubMed ID: 11675828)
21. GUSTO IV: expanding therapeutic options in acute coronary syndromes.
Lincoff AM
Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004
[No Abstract] [Full Text] [Related]
22. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
[TBL] [Abstract][Full Text] [Related]
23. Thrombolytic therapy: new dimensions 2009.
Guha S; Mukherjee S; Hema MB
Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
[No Abstract] [Full Text] [Related]
24. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
Eccleston D; Topol EJ
Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
[No Abstract] [Full Text] [Related]
25. Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibition.
Bush HS
J Emerg Med; 2003 Nov; 25(4):421-6. PubMed ID: 14654184
[TBL] [Abstract][Full Text] [Related]
26. Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.
Kaplan AL; Goldmann B; Ohman EM
J Emerg Med; 1999; 17(3):589-95. PubMed ID: 10338261
[No Abstract] [Full Text] [Related]
27. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction.
Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G
Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497
[TBL] [Abstract][Full Text] [Related]
28. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
Collins R; Peto R; Baigent C; Sleight P
N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
[No Abstract] [Full Text] [Related]
29. Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.
Campbell KR; Cantor W; Sketch M; Ohman EM
Am Heart J; 2000 Dec; 140(6 Suppl):S115-24. PubMed ID: 11100005
[No Abstract] [Full Text] [Related]
30. The GUSTO-V clinical trial.
Lincoff AM
J Invasive Cardiol; 2002 Feb; 14 Suppl A():21A-30A. PubMed ID: 11847403
[No Abstract] [Full Text] [Related]
31. Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction.
Manoharan G; Adgey AA
Clin Cardiol; 2004 Jul; 27(7):381-6. PubMed ID: 15298036
[TBL] [Abstract][Full Text] [Related]
32. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
Padma V; Fisher M; Moonis M
Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
[TBL] [Abstract][Full Text] [Related]
33. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
Huynh T; Theroux P; Snapinn S; Wan Y;
Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
[TBL] [Abstract][Full Text] [Related]
34. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
Lincoff AM
Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
[TBL] [Abstract][Full Text] [Related]
35. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction.
Vivekananthan DP; Patel VB; Moliterno DJ
J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808
[TBL] [Abstract][Full Text] [Related]
36. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
Waters RE; Mahaffey KW; Granger CB; Roe MT
Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
[TBL] [Abstract][Full Text] [Related]
37. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
Otterstad JE; Brosstad F
Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
[No Abstract] [Full Text] [Related]
38. [Multi-drug management after myocardial infarct].
Kritz H; Sinzinger H
Wien Klin Wochenschr; 1997; 109 Suppl 2():17-24. PubMed ID: 9340918
[TBL] [Abstract][Full Text] [Related]
39. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction.
Verheugt FW
Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678
[TBL] [Abstract][Full Text] [Related]
40. Reperfusion synergism: will it be both sustained and safe?
Armstrong PW
Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
